NRC Health (NRC)
Official siteHEALTHCARE • HEALTH INFORMATION SERVICES • NASDAQ
Market Cap: $563.64M
Last updated: Nov 17, 2026 at 11:05 AM ET
NRC Health (NRC) Financials: Revenue, Profit and Cash Flow
NRC Health reported revenue of $137.39M for the fiscal year ended Dec 31, 2025, down 4.0% from the year before. That year, net income was $11.60M with a net margin of 8.4%, operating cash flow was $26.45M and free cash flow was $15.74M. The quarter ended Sep 30, 2026 had revenue of $38.40M and net income of $4.70M.
Revenue and Margins
The operating margin was 16.4% in the fiscal year ended Dec 2025, the lowest of the 10 years shown. Over the 9 years to Dec 2025, revenue grew from $109.38M, a compound annual rate of 2.6%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $137.39M | -4.0% | 100.0% | 16.4% | 8.4% |
| Dec 2024 | $143.06M | -3.7% | 100.0% | 24.6% | 17.3% |
| Dec 2023 | $148.58M | -2.0% | 100.0% | 27.0% | 20.8% |
| Dec 2022 | $151.57M | +2.4% | 100.0% | 30.7% | 21.0% |
| Dec 2021 | $147.95M | +11.0% | 100.0% | 34.0% | 25.3% |
| Dec 2020 | $133.28M | +4.1% | 100.0% | 32.0% | 28.0% |
| Dec 2019 | $127.98M | +6.9% | 100.0% | 33.6% | 25.3% |
| Dec 2018 | $119.69M | +1.8% | 100.0% | 29.5% | 25.1% |
| Dec 2017 | $117.56M | +7.5% | 100.0% | 29.1% | 19.5% |
| Dec 2016 | $109.38M | N/A | 100.0% | 28.5% | 18.8% |
Income Statement
In the fiscal year ended Dec 2025, net income fell 53.2% from the year before. In the quarter ended Sep 2026, net income rose 14.1% from the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $137.39M | $143.06M | $148.58M | $151.57M | $147.95M | $133.28M | $127.98M | $119.69M | $117.56M | $109.38M |
| Gross profit | $137.39M | $143.06M | $148.58M | $151.57M | $147.95M | $133.28M | $127.98M | $119.69M | $117.56M | $109.38M |
| Operating income | $22.59M | $35.19M | $40.05M | $46.54M | $50.27M | $42.68M | $43.03M | $35.27M | $34.22M | $31.20M |
| Net income | $11.60M | $24.78M | $30.97M | $31.80M | $37.47M | $37.26M | $32.41M | $30.05M | $22.94M | $20.52M |
| EBITDA | $30.22M | $41.21M | $45.94M | $49.13M | $56.65M | $50.77M | $48.11M | $41.62M | $38.85M | $35.72M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $38.40M | $35.39M | $34.80M | $35.19M | $34.61M | $34.04M | $33.55M | $36.91M | $35.82M | $35.02M | $35.31M | $38.00M |
| Gross profit | $38.40M | $35.39M | $34.80M | $35.19M | $34.61M | $34.04M | $33.55M | $36.91M | $35.82M | $35.02M | $35.31M | $38.00M |
| Operating income | $8.91M | -$3.24M | $5.57M | $4.67M | $7.74M | $1.59M | $8.60M | $9.59M | $7.98M | $8.87M | $8.76M | $11.71M |
| Net income | $4.70M | -$3.28M | $3.22M | $1.80M | $4.12M | -$106.00K | $5.79M | $6.56M | $5.69M | $6.17M | $6.36M | $8.86M |
Balance Sheet
As of Dec 2025, total debt of $79.03M exceeded cash and equivalents by $74.90M.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $134.88M | $132.54M | $122.44M | $130.46M | $157.54M | $133.42M | $110.69M | $108.03M | $127.32M | $120.62M |
| Current assets | $20.21M | $19.60M | $24.36M | $43.72M | $73.71M | $54.11M | $29.16M | $28.41M | $52.26M | $47.06M |
| Cash and equivalents | $4.14M | $4.23M | $6.65M | $25.03M | $54.36M | $34.69M | $13.52M | $12.99M | $34.73M | $33.02M |
| Total liabilities | $120.89M | $101.25M | $73.48M | $58.43M | $72.20M | $69.11M | $77.79M | $88.95M | $37.27M | $37.82M |
| Short-term debt | $4.01M | $4.79M | $7.21M | $4.49M | $4.28M | $4.06M | $4.38M | $3.67M | $1.14M | $2.77M |
| Long-term debt | $75.02M | $57.90M | $29.47M | $17.69M | $22.27M | $26.55M | $29.80M | $34.18M | $0 | $857.00K |
| Shareholder equity | $13.99M | $31.28M | $48.95M | $72.03M | $85.34M | $64.31M | $32.89M | $19.08M | $90.04M | $82.81M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $139.21M | $136.15M | $134.56M | $134.88M | $135.72M | $141.39M | $135.18M | $132.54M | $131.80M | $119.10M | $120.91M | $122.44M |
| Total liabilities | $148.34M | $129.60M | $121.06M | $120.89M | $121.41M | $120.06M | $105.50M | $101.25M | $97.17M | $78.90M | $83.97M | $73.48M |
| Cash and equivalents | $3.63M | $3.33M | $2.55M | $4.14M | $2.22M | $5.27M | $2.50M | $4.23M | $3.46M | $485.00K | $1.70M | $6.65M |
| Shareholder equity | -$9.12M | $6.55M | $13.49M | $13.99M | $14.31M | $21.33M | $29.67M | $31.28M | $34.62M | $40.20M | $36.95M | $48.95M |
Cash Flow
In the fiscal year ended Dec 2025, free cash flow was 59.5% of operating cash flow. Dividends and share repurchases together came to 198.0% of it.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $26.45M | $34.63M | $38.11M | $36.27M | $46.34M | $40.64M | $40.92M | $39.85M | $28.09M | $26.84M |
| Capital expenditures | $10.71M | $15.45M | $15.78M | $9.84M | $5.51M | $3.98M | $4.66M | $5.97M | $4.57M | $3.97M |
| Free cash flow | $15.74M | $19.18M | $22.33M | $26.43M | $40.83M | $36.65M | $36.26M | $33.88M | $23.52M | $22.87M |
| Dividends paid | $10.98M | $11.45M | $36.37M | $20.96M | $9.16M | $10.52M | $31.30M | $16.86M | $16.87M | $30.55M |
| Share repurchases | $20.18M | $30.95M | $19.10M | $27.62M | $4.14M | $0 | $0 | N/A | N/A | N/A |
| Investing cash flow | -$10.71M | -$20.28M | -$15.78M | -$9.84M | -$8.51M | -$3.72M | -$4.66M | -$5.97M | -$6.12M | -$3.75M |
| Financing cash flow | -$15.84M | -$16.76M | -$40.71M | -$55.58M | -$18.16M | -$15.50M | -$36.35M | -$54.50M | -$21.12M | -$32.50M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $8.02M | $1.39M | $7.18M | $7.18M | $13.76M | -$1.14M | $6.65M | $6.38M | $9.42M | $6.79M | $12.04M | $11.71M |
| Capital expenditures | $1.04M | $1.32M | $1.83M | $1.12M | $3.59M | $3.01M | $2.99M | $4.44M | $1.60M | $5.27M | $4.14M | $3.77M |
| Free cash flow | $6.98M | $62.00K | $5.35M | $6.06M | $10.18M | -$4.15M | $3.66M | $1.94M | $7.83M | $1.52M | $7.90M | $7.94M |
Frequently Asked Questions About NRC
What is NRC Health's annual revenue?
NRC Health reported revenue of $137.39M for the fiscal year ended Dec 31, 2025.
How fast is NRC Health's revenue growing?
Revenue was down 4.0% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was -3.2%.
Is NRC Health profitable?
Yes. NRC Health reported net income of $11.60M for the fiscal year ended Dec 31, 2025, with a net margin of 8.4%.
How much free cash flow does NRC generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of $26.45M minus capital expenditures of $10.71M produced free cash flow of $15.74M.
How much debt does NRC Health have?
The balance sheet dated Dec 31, 2025 reported long-term debt of $75.02M, short-term debt of $4.01M and cash and equivalents of $4.14M.
NRC pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors